Dr. Scott Rocklage works hard at perfecting all of the multiple tasks involved with his position as managing partner at 5AM Ventures. Perfection, in this case, meaning completion of a diverse group of responsibilities. Most notably, he has seen through to completion the approval of 3 new medications with the U.S. FDA.
These accomplishments have been very beneficial to the healthcare sector. New drugs and procedures are helping to make healthcare in the United States better for all patients.
Dr. Rocklage also balances a successful career with a balanced home life. He is married to Patty Rocklage. Both he and his wife have given major gifts to help with the renovation and development at his Alma Mater Massachusetts Institute of Technology (MIT).
The laboratory in the Chemistry department will continue the long tradition of cultivating great scientist. Dr. Rocklage credits MIT with giving him the firm foundation to have a successful career. Learn more about Scott Rocklage: http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY and http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/
MIT did provide the basis for Dr. Rocklage’s extensive knowledge of chemistry by awarding him a Ph.D. In 1982 in the field of Chemistry. He also has an undergraduate B.S. degree in Chemistry from UC Berkeley.
He has used this knowledge to become an accomplished inventor with 30 successful patents in the U.S filed. In addition to being a successful inventor, he has also published over 100 per reviewed publications.
Prior to his current position at 5AM Ventures, Dr. Scott Rocklage has worked at many organizations in the healthcare field. Some of these recognizable organizations include, Cubist Pharmaceuticals, Novira and Relypsa.
At both Novira and Relypsa, he was in a key position at the organizations as Chairman of the Board. He continues to contribute to biomedical research by serving as a Board Associate at the Whitehead Institute.
His executive positions at various companies in the healthcare field has helped to fuel innovation. Dr. Rocklage’s continued legacy will also include helping future scientist with his philanthropic endeavors at MIT.
Research articles are also used by others when looking for ways to improve different medications and healthcare processes. Dr. Rocklage is also highly regarded among his peers for his many published articles.